“Post-COVID syndrome”: The focus is on musculoskeletal pain
Combating the consequences of COVID-19, a disease caused by the new coronavirus infection SARS-CoV-2, is a serious and very urgent task facing modern medicine. COVID-19 often has a severe course and is accompanied by multiple organ damage, systemic immune inflammation, coagulopathy, neuroendocrine a...
Saved in:
| Main Authors: | A. E. Karateev, V. N. Amirdzhanova, E. L. Nasonov, A. M. Lila, L. I. Alekseeva, E. Yu. Pogozheva, E. S. Filatova, V. A. Nesterenko |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA PRESS LLC
2021-07-01
|
| Series: | Научно-практическая ревматология |
| Subjects: | |
| Online Access: | https://rsp.mediar-press.net/rsp/article/view/3035 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Diacerein in the treatment of chronic musculoskeletal pain
by: E. Yu. Polishchuk, et al.
Published: (2022-06-01) -
GENERAL PRINCIPLES OF TREATMENT FOR MUSCULOSKELETAL PAIN: INTERDISCIPLINARY CONSENSUS
by: E. L. Nasonov, et al.
Published: (2016-07-01) -
The problem of musculoskeletal pain: what is interesting for the practitioner? Data of a survey of 846 Russian physicians
by: A. E. Karateev
Published: (2019-05-01) -
Use of tanezumab for chronic pain treatment
by: A. E. Karateev, et al.
Published: (2021-05-01) -
Improving the efficacy of musculoskeletal pain therapy: the role of B-group vitamins combination (descriptive review)
by: A. E. Karateev
Published: (2025-06-01)